tm logo
SYNETS
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 10 Apr 2024

Last Applicant/ Owned by

8/36 O'Riordan Street

Alexandria

AU

NSW,2015

Serial Number

97779299 filed on 03rd Feb 2023

Registration Number

N/A

Correspondent Address

Jennifer A. Visintine THOMPSON COBURN LLP

ONE US BANK PLAZA

ST. LOUIS, MO 63101

UNITED STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

SYNETS

Food supplements, namely, anti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; CollaRead More

Classification Information


Class [005]
Pharmaceutical Products


Food supplements, namely, anti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for medical purposes; Herbal dietary supplements; Dietary nutritional supplements; Nutritional supplements; Medicinal plant compounds for use as dietary supplements; Plant compounds for use as veterinary dietary supplements ; Plant extracts being dietary supplements; Medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; Pharmaceutical drugs to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for skin care; Pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Chemical products for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Natural pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Tablets being pharmaceuticals to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for animals in the nature of vitamins; Vitamin supplements; Dietary food supplements; Nutritional drinks being dietary food supplements; Food supplements in the nature of dietary supplements


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Mark Details


Serial Number

No 97779299

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 69016-225505

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
09th Apr 2024TEAS/EMAIL CORRESPONDENCE ENTERED
09th Apr 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
09th Apr 2024ASSIGNED TO LIE
17th Nov 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12th Nov 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12th Nov 2023LETTER OF SUSPENSION E-MAILED
12th Nov 2023SUSPENSION LETTER WRITTEN
08th Nov 2023EXAMINER'S AMENDMENT ENTERED